IRIS
BELFIORI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.149
AS - Asia 1.604
NA - Nord America 1.522
SA - Sud America 207
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 39
OC - Oceania 2
Totale 5.696
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.417
RU - Federazione Russa 1.116
SG - Singapore 611
CN - Cina 487
IT - Italia 330
RO - Romania 265
BR - Brasile 162
HK - Hong Kong 152
VN - Vietnam 116
BD - Bangladesh 91
DE - Germania 90
FR - Francia 70
CA - Canada 61
GB - Regno Unito 56
FI - Finlandia 48
IN - India 48
SE - Svezia 38
PL - Polonia 32
NL - Olanda 26
ES - Italia 23
MX - Messico 22
AT - Austria 20
AR - Argentina 19
JP - Giappone 17
ZA - Sudafrica 17
ID - Indonesia 11
MY - Malesia 11
TR - Turchia 11
EC - Ecuador 10
IQ - Iraq 9
LT - Lituania 8
CR - Costa Rica 7
IE - Irlanda 6
KE - Kenya 6
BE - Belgio 5
CO - Colombia 5
JM - Giamaica 5
PH - Filippine 5
PK - Pakistan 5
UA - Ucraina 5
IL - Israele 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
HU - Ungheria 3
MA - Marocco 3
NP - Nepal 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
DZ - Algeria 2
HN - Honduras 2
IR - Iran 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
BB - Barbados 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CH - Svizzera 1
EE - Estonia 1
GR - Grecia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
PR - Porto Rico 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
Totale 5.524
Salva come PNG Salva come JPEG
Città #
Singapore 360
Moscow 216
Ashburn 207
San Jose 167
Hong Kong 150
Dallas 118
New York 80
Council Bluffs 79
Beijing 74
Milan 74
Shanghai 67
Los Angeles 58
Hefei 44
Santa Clara 42
Ho Chi Minh City 39
Lauterbourg 37
Boardman 36
Orem 36
Rome 34
São Paulo 29
Hanoi 23
Helsinki 22
Nuremberg 22
Munich 21
Warsaw 21
Frankfurt am Main 19
Chicago 18
Montreal 18
Phoenix 18
Stockholm 18
Buffalo 17
Chennai 17
Denver 17
Poplar 15
Toronto 15
Brescia 14
Brooklyn 14
Johannesburg 13
Lappeenranta 13
Turku 13
Atlanta 12
Amsterdam 11
Cesano Boscone 11
Vienna 11
Boston 10
Seattle 10
Guangzhou 9
Houston 9
London 9
Manchester 9
Mexico City 9
Pisa 9
Tokyo 9
Assago 8
Memphis 7
Naples 7
Omaha 7
Ottawa 7
Perugia 7
Pune 7
Rio de Janeiro 7
Tianjin 7
Charlotte 6
Dublin 6
Falkenstein 6
Hangzhou 6
Mumbai 6
San José 6
Bologna 5
Brasília 5
Brussels 5
Calgary 5
Carlsbad 5
Figino 5
Florence 5
Guayaquil 5
Jiaxing 5
Querétaro 5
San Francisco 5
Shenzhen 5
St Louis 5
The Dalles 5
Turin 5
Verdellino 5
Ankara 4
Baghdad 4
Belo Horizonte 4
Bexley 4
Cagliari 4
City of London 4
Cleveland 4
Da Nang 4
Dalian 4
Kuala Lumpur 4
Las Vegas 4
Nairobi 4
Providence 4
Tashkent 4
Thái Bình 4
Wroclaw 4
Totale 2.667
Salva come PNG Salva come JPEG
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 363
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 194
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 182
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 177
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 146
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 134
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 134
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 127
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 124
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 123
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 122
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 119
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 117
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 116
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 114
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 114
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 112
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 111
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 111
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 110
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 110
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 110
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 108
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 107
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 105
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 103
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 103
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 103
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 102
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 102
Risk factors for the occurrence of ampullary tumors: A case-control study 97
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a “Biological R2 Definition” 92
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 90
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease 87
Surgical Planning for “Borderline Resectable” and “Locally Advanced” Pancreatic Cancer During Open Pancreatic Resection 85
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 81
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy 80
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 80
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 79
Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature 78
ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist? 76
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 75
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer 74
Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground 71
Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study 69
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 68
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 65
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 64
Clinical features and evolution of paraduodenal (groove) pancreatitis: A multicenter study 59
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 55
Preoperative prediction of metastatic body-tail peripancreatic lymph nodes as a guide for surgical decision-making in pancreatic neck ductal adenocarcinoma 54
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength 53
Response to ‘Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer’ 36
Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-institutional Analysis 29
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study 26
Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment 25
ASO Visual Abstract: Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment 10
Clinico-pathological features and prognosis of mixed-IPMNs with a focal involvement of the main pancreatic duct 10
Endoscopic ultrasound-guided gallbladder drainage in acute cholecystitis with contained perforation: a prospective cohort study 8
ASO Author Reflections: Early Disease-Related Mortality After Neoadjuvant Therapy and Radical Resection for Pancreatic Ductal Adenocarcinoma—The Biological Burden Beyond Resectability 6
IgG4-related autoimmune pancreatitis mimicking a degenerating intraductal papillary mucinous neoplasm 6
Real life management of intraductal papillary mucinous neoplasms of the pancreas: Final data from the prospective Italian pancreatic cysts (PANCY) registry 5
Totale 5.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/202353 3 2 1 0 2 7 11 10 0 0 10 7
2023/2024237 3 12 27 31 23 39 11 22 3 0 31 35
2024/20251.160 62 20 41 66 73 77 391 103 123 51 66 87
2025/20263.928 220 192 129 418 379 136 330 359 1.052 242 256 215
2026/2027316 122 194 0 0 0 0 0 0 0 0 0 0
Totale 5.696